Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
11 Jan 2024
Vaccine
DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Sanofi S.A - Digital Transformation Strategies" company profile has been added to
ResearchAndMarkets.com's offering.
This report provides insight into Sanofi's digital technology activities, including its digital transformation strategies, its accelerators, incubators, and other innovation programs, its technology initiatives, venture arm, investments, and its estimated ICT budget.
Sanofi S.A. (Sanofi) is a France-based multinational healthcare company. It is engaged in the discovery, development, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and consumer healthcare products for digestion, allergy, cough, cold, flu and sinus, pain, women's health, and supplements.
The company has three operating segments namely Vaccines, Pharmaceuticals, and Consumer Healthcare. The Pharmaceuticals segment comprises the operations of Specialty Care and General Medicines. The company reports its sales through four divisions namely General Medicines, Specialty Care, Vaccines and Consumer Healthcare.
The company is using several emerging technologies such as AI, ML, big data, and cloud among others, has launched accelerators and innovation hubs, and is partnering with and investing in digital companies to enhance operational efficiencies, quickly develop new medicines and vaccines, and improve patient outcomes.
Scope
Sanofi is strengthening its focus on the use of innovative technologies to enhance operational efficiencies, quickly develop new medicines and vaccines, and improve patient outcomes. AI, ML, cloud, big data, virtual and augmented reality, connected care and robotics, are among the technologies the pharmaceutical company is focusing on.
Reasons to Buy
Gain insights into Sanofi's digital transformation strategies.
Gain insights into its technology themes under focus.
Gain insights into its various product launches, partnerships, and investments.
Key Topics Covered:
Overview
Digital Transformation Strategy
Accelerators, Incubators, and Other Innovation Programs
Technology Focus
Technology Initiatives
Venture Arm: Sanofi Ventures
Investment
Partnership & Investment Network Map
ICT Budget and Contracts
Key Executives
A selection of companies mentioned in this report includes
Aqemia
Yseop
Abdul Latif Jameel Clinic for Machine Learning in Health
Owkin
CentraleSupelec
Babylon
Happify
Voxly Digital
Atman
Researchably
McLaren Racing
Evidation
Orange
Health2Sync
Aetion
MDConnect
HakoBio
Abbott
Gyenno
Vizibl
Aetion
Nucleai
Medisafe
Glooko
For more information about this company profile visit https://www.researchandmarkets.com/r/kwrwr9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.